|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01715 AI HEALTH TECH
Nominal 
0.420 0.000 (0.000%) | 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Turnover | 42,972 | 79.499% | 47,404 | 91,885 | 84,369 | 88,186 |
| Cost of Sales | (40,431) | 87.737% | (43,140) | (85,400) | (63,152) | (49,699) |
| Gross Profit | 2,541 | 5.699% | 4,264 | 6,485 | 21,217 | 38,487 |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | 330 | -71.722% | 1,598 | (4,024) | (5,715) | (2,059) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (143) | -24.339% | (1,025) | (342) | (566) | (393) | |
| Profit / (Loss) before Taxation | (19,452) | 69.207% | (35,963) | (35,958) | (49,283) | (43,206) | |
| Taxation | (32) | 88.235% | (53) | (47) | (35) | (344) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 20 | 53.846% | 455 | 155 | 0 | 337 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (19,464) | 69.252% | (35,561) | (35,850) | (49,318) | (43,213) | |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 1,402 | 4.862% | 2,714 | 4,157 | 7,703 | 5,002 |
| Depreciation & Amortisation | 1,037 | -28.136% | 2,654 | 4,238 | 5,514 | 7,205 |
| Directors' Emoluments | -- | -- | -- | 662 | 1,417 | 1,502 |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified (Modified Report) | Unqualified |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| EPS (cts) | -5.000 | -37.500% | -13.000 | -5.000 | -63.875 | -63.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | (0.038) | (0.049) | 0.216 | (1.265) |
| NBV per share ($) | 0.107 | -- | 0.163 | 0.312 | 0.674 | 1.17196 |
| Remarks: | Real time quote last updated: 04/09/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -19,464 |
| %Change | 69.252% |
| EPS / (LPS) | RMB -0.050 |
| NBV Per Share (¥) | RMB 0.107 |